The Role of Emotional Stress in Patients With Stress-induced Cardiomyopathy

February 10, 2015 updated by: Dr. Samir Said, University of Magdeburg

Event-related Potentials in Patients With Takotsubo Cardiomyopathy

The event-related potentials may be different in patients with Takotsubo cardiomyopathy than in patients without Takotsubo.

Study Overview

Status

Unknown

Detailed Description

In patients with Takotsubo diagnosed by coronary angiography, the event-related potentials are investigated and compared with a control group, which consists of subjects without Takotsubo.

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Magdeburg, Germany, 39112
        • Recruiting
        • University Hospital Magdeburg
        • Principal Investigator:
          • Samir M Said, MD
        • Sub-Investigator:
          • Katja Mueller

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with Takotsubo Cardiomyopathy compared with healthy subjects and patients with ACS.

Description

Inclusion Criteria:

  • Age >18 years
  • Written informed consent
  • Takotsubo cardiomyopathy for group 1. ACS for group 3.

Exclusion Criteria:

  • Psychiatric diseases
  • Impaired versus, non compliant patients, heart disease for group 2.
  • Takotsubo-like syndrome.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Healthy
Takotsubo
ACS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Event-related potentials
Time Frame: up to 1 year
up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2011

Primary Completion (Anticipated)

August 1, 2015

Study Completion (Anticipated)

August 1, 2015

Study Registration Dates

First Submitted

January 9, 2013

First Submitted That Met QC Criteria

February 10, 2015

First Posted (Estimate)

February 11, 2015

Study Record Updates

Last Update Posted (Estimate)

February 11, 2015

Last Update Submitted That Met QC Criteria

February 10, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Takotsubo Cardiomyopathy

3
Subscribe